top of page
  • Facebook
  • X
  • LinkedIn
  • YouTube

 Supporting progress &  translation of
gene & cell therapies 

Annual Conference

The BSGCT's 2024 Annual Conference took place on 17-19 June in Oxford

20th Anniversary

Last year BSGCT celebrated its 20th anniversary! Take a look at our history, achievements and future plans.

Become a Member

Subscribe as a BSGCT member to join our community and receive membership benefits

The aim of the British Society for Gene and Cell Therapy is to support scientific progress and promote ethical and efficient translation of gene- and cell-based technologies from the laboratory into the clinic.

Gene and cell therapy is an area where co-operation between all interested parties – general public, patients, scientists, companies, government and the media – is vital for the optimal development of these technologies and treatments, and the BSGCT is working towards becoming this pro-active platform of collaboration and knowledge sharing. 

As part of our efforts, we run an annual conference. We run three online seminar series: the Research Seminars, dedicated to sharing the latest developments in gene and cell therapies, the Public and Patient Series, designed to provide lay introductions to gene and cell therapy and the Early Career Researchers Series, dedicated to engage in relevant topics for career development in the field. Most of our seminars are recorded and can be found on our YouTube Channel.


We also run a monthly blog exploring different scientific topics and a newsletter with relevant news, event highlights and a "researcher of the month" section to explore what our members and other researchers are working on. 

Most of our activities are organised and run by our board and sub-committees members, supported by volunteers. As a charity, the support of our sponsors and members has the utmost importance.


We invite you to get involved with us and help us make gene and cell therapies accessible for everyone.


News and Jobs





Join Us

Become a member of the Society dedicated to support scientific progress

bottom of page